Korro Bio, Inc. Common Stock (KRRO) is a publicly traded Healthcare sector company. As of July 11, 2026, KRRO trades at $14.55 with a market cap of $206.24M and a P/E ratio of -1.14. KRRO moved +0.87% today. Year to date, KRRO is +81.77%; over the trailing twelve months it is +7.14%. Its 52-week range spans $5.20 to $56.69. Analyst consensus is strong buy with an average price target of $19.00. Rallies surfaces KRRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for KRRO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $14.55 |
| Market Cap | $206.24M |
| P/E Ratio | -1.14 |
| EPS | $-12.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $56.69 |
| 52-Week Low | $5.20 |
| Volume | 208.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.39M |
| Net Income | $-117.26M |
| Gross Margin | 0.00% |
8 analysts cover KRRO: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.00.